創傷閉鎖デバイス:医療機器パイプライン分析

◆英語タイトル:Wound Closure Devices - Medical Devices Pipeline Assessment, 2019
◆商品コード:GDT20FB0190
◆発行会社(リサーチ会社):GlobalData
◆発行日:2019年12月
◆ページ数:610
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール(受注後24時間以内)
◆調査対象地域:グローバル
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,000 ⇒換算¥440,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD8,000 ⇒換算¥880,000見積依頼/購入/質問フォーム
Enterprisewide Price(複数事業所内共有可)USD12,000 ⇒換算¥1,320,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の医療分野調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。
※上記「見積依頼/購入/質問フォーム」をクリックすると弊社運営のレポート販売サイトに移動します。

【レポートの概要】

Wound Closure Devices – Medical Devices Pipeline Assessment, 2019
Summary

GlobalData’s Medical Devices sector report, “Wound Closure Devices – Medical Devices Pipeline Assessment, 2019″ provides an overview of Wound Closure Devices currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Wound Closure Devices pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData’s team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

- Extensive coverage of the Wound Closure Devices under development
- The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
- The report reviews the major players involved in the development of Wound Closure Devices and list all their pipeline projects
- The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
- The report provides key clinical trial data of ongoing trials specific to pipeline products
- Recent developments in the segment / industry

Reasons to buy

The report enables you to –
- Formulate significant competitor information, analysis, and insights to improve R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand important and diverse types of Wound Closure Devices under development
- Develop market-entry and market expansion strategies
- Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
- In-depth analysis of the product’s current stage of development, territory and estimated launch date

【レポートの目次】

Table of Contents
1.1 List of Tables 15
1.2 List of Figures 28
2 Introduction 29
2.1 Wound Closure Devices Overview 29
3 Products under Development 32
3.1 Wound Closure Devices – Pipeline Products by Stage of Development 32
3.2 Wound Closure Devices – Pipeline Products by Segment 33
3.3 Wound Closure Devices – Pipeline Products by Territory 35
3.4 Wound Closure Devices – Pipeline Products by Regulatory Path 36
3.5 Wound Closure Devices – Pipeline Products by Estimated Approval Date 37
3.6 Wound Closure Devices – Ongoing Clinical Trials 38
4 Wound Closure Devices – Pipeline Products under Development by Companies 39
4.1 Wound Closure Devices Companies – Pipeline Products by Stage of Development 39
4.2 Wound Closure Devices – Pipeline Products by Stage of Development 45
5 Wound Closure Devices Companies and Product Overview 51
6 Wound Closure Devices- Recent Developments 299
7 Appendix 595

List of Tables
Table 1: Wound Closure Devices - Pipeline Products by Stage of Development 32
Table 2: Wound Closure Devices - Pipeline Products by Segment 33
Table 3: Wound Closure Devices - Pipeline Products by Territory 35
Table 4: Wound Closure Devices - Pipeline Products by Regulatory Path 36
Table 5: Wound Closure Devices - Pipeline Products by Estimated Approval Date 37
Table 6: Wound Closure Devices - Ongoing Clinical Trials 38
Table 7: Wound Closure Devices Companies - Pipeline Products by Stage of Development 39
Table 8: Wound Closure Devices - Pipeline Products by Stage of Development 45
Table 9: 3-D Matrix Ltd Pipeline Products & Ongoing Clinical Trials Overview 51
Table 10: PuraStat Hemostat - Product Status 52
Table 11: PuraStat Hemostat - Product Description 52
Table 12: TDM-511 - Product Status 53
Table 13: TDM-511 - Product Description 53
Table 14: TDM-623 - Product Status 53
Table 15: TDM-623 - Product Description 54
Table 16: TDM-651 - Product Status 54
Table 17: TDM-651 - Product Description 54
Table 18: 3-D Matrix Ltd - Ongoing Clinical Trials Overview 55
Table 19: PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of Purastat Absorbable Haemostatic Material for the Management of Bleeding after Open Liver Resection 56
Table 20: PuraStat Hemostat - A Multi-center, Single Arm Post-market Clinical Study to Confirm Safety and Performance of PuraStat Absorbable Haemostatic Material for the Management of Bleeding in Vascular Surgery 56
Table 21: PuraStat Hemostat - A Multicenter Prospective Observational Study to Evaluate the Utilization, Effectiveness and Safety of Purastat in the Management of Gastrointestinal Bleeding 57
Table 22: PuraStat Hemostat - The Hemostatic Potential of TDM-621 on Ascending Aortic Surgery 57
Table 23: ACell Inc Pipeline Products & Ongoing Clinical Trials Overview 58
Table 24: MicroMatrix - Product Status 58
Table 25: MicroMatrix - Product Description 58
Table 26: ACell Inc - Ongoing Clinical Trials Overview 59
Table 27: MicroMatrix - A Single Site Randomized, Clinical Trial Comparing the Concomitant Use of MicroMatrix with Cytal Wound Matrix 2-Layer to Standard of Care in Patients with Stage 3 or 4 Pressure Injuries 60
Table 28: MicroMatrix - The Management of Pilonidal Wounds With ACell MicroMatrix® and Cytal® Wound Matrix: A Case Series 60
Table 29: MicroMatrix - Use of Cytal Wound Matrix and MicroMatrix for the Management of Wounds 60
Table 30: Actamax Surgical Materials LLC Pipeline Products & Ongoing Clinical Trials Overview 61
Table 31: Actamax Adhesion Barrier - Product Status 61
Table 32: Actamax Adhesion Barrier - Product Description 61
Table 33: Actamax Surgical Materials LLC - Ongoing Clinical Trials Overview 62
Table 34: Actamax Adhesion Barrier - A Randomized, Controlled, Multi-center Study to Assess the Safety and Efficacy of Actamax Adhesion Barrier in Women undergoing Laparoscopic Abdominopelvic Surgery with a Myomectomy Followed by Second Look Laparoscopy (SLL) 63
Table 35: Adhesys Medical GmbH Pipeline Products & Ongoing Clinical Trials Overview 64
Table 36: CUTIS - Product Status 64
Table 37: CUTIS - Product Description 64
Table 38: VIVO - Product Status 65
Table 39: VIVO - Product Description 65
Table 40: Advanced Medical Solutions Group plc Pipeline Products & Ongoing Clinical Trials Overview 66
Table 41: Large Wounds Closure Device - Product Status 66
Table 42: Large Wounds Closure Device - Product Description 66
Table 43: LiquiBand - Product Status 67
Table 44: LiquiBand - Product Description 67
Table 45: LiquiBand Exceed - Product Status 67
Table 46: LiquiBand Exceed - Product Description 68
Table 47: LiquiBand Flow Control - Product Status 68
Table 48: LiquiBand Flow Control - Product Description 68
Table 49: Next Generation Internal Fixation And Sealant Device - Product Status 69
Table 50: Next Generation Internal Fixation And Sealant Device - Product Description 69
Table 51: Advanced Medical Solutions Group plc - Ongoing Clinical Trials Overview 70
Table 52: LiquiBand Exceed - Trial Investigating Cyanoacrylate Glue to Prevent Surgical Site Infection Following Breast Surgery 71
Table 53: AFYX Therapeutics A/S Pipeline Products & Ongoing Clinical Trials Overview 72
Table 54: Rivelin Plain Patch - Product Status 72
Table 55: Rivelin Plain Patch - Product Description 72
Table 56: Alafair Biosciences Inc Pipeline Products & Ongoing Clinical Trials Overview 73
Table 57: VersaWrap Adhesion Barrier - Product Status 73
Table 58: VersaWrap Adhesion Barrier - Product Description 73
Table 59: Albert Ludwigs University of Freiburg Pipeline Products & Ongoing Clinical Trials Overview 74
Table 60: Biohybrid Membrane - Product Status 74

List of Figures
Figure 1: Wound Closure Devices - Pipeline Products by Stage of Development 32
Figure 2: Wound Closure Devices - Pipeline Products by Segment 33
Figure 3: Wound Closure Devices - Pipeline Products by Territory 35
Figure 4: Wound Closure Devices - Pipeline Products by Regulatory Path 36
Figure 5: Wound Closure Devices - Pipeline Products by Estimated Approval Date 37
Figure 6: Wound Closure Devices - Ongoing Clinical Trials 38

【免責事項】
https://www.marketreport.jp/reports-disclaimer

★医療情報レポート[創傷閉鎖デバイス:医療機器パイプライン分析]についてメールでお問い合わせはこちら



◆H&Iグローバルリサーチ株式会社のお客様(例)◆